$55.96
0.81[1.47%]
At close: May 3
$55.96
0[0.00%]
After Hours: 7:49PM EDT
CVS Health
(NYSE:CVS)CVS Health Stock (NYSE:CVS), Analyst Ratings, Price Targets, Predictions
CVS Health Corp has a consensus price target of $91.03, established from looking at the 100 latest analyst ratings. The last 3 analyst ratings were released from B of A Securities, Goldman Sachs, and Barclays on May 2, 2024. With an average price target of $71.33 between B of A Securities, Goldman Sachs, and Barclays, there's an implied 27.47% upside for CVS Health Corp from these 3 analyst ratings.
Analyst Firms Making Recommendations1
B of A Securities
Goldman Sachs
Barclays
UBS
Truist Securities
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for CVS Health
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 05/02/2024 | CVS | Buy Now | CVS Health | $55.96 | 37.6% | B of A Securities | Michael Cherny | $95 → $77 | Maintains | Buy | Get Alert |
| 05/02/2024 | CVS | Buy Now | CVS Health | $55.96 | 32.24% | Goldman Sachs | Nathan Rice | $85 → $74 | Maintains | Buy | Get Alert |
| 05/02/2024 | CVS | Buy Now | CVS Health | $55.96 | 12.58% | Barclays | Andrew Mok | $78 → $63 | Maintains | Equal-Weight | Get Alert |
| 05/02/2024 | CVS | Buy Now | CVS Health | $55.96 | 7.22% | UBS | Kevin Caliendo | $85 → $60 | Downgrade | Buy → Neutral | Get Alert |
| 05/02/2024 | CVS | Buy Now | CVS Health | $55.96 | 17.94% | Truist Securities | David Macdonald | $90 → $66 | Reiterates | Buy → Buy | Get Alert |
| 05/02/2024 | CVS | Buy Now | CVS Health | $55.96 | 28.66% | Mizuho | Ann Hynes | $86 → $72 | Maintains | Buy | Get Alert |
| 05/01/2024 | CVS | Buy Now | CVS Health | $55.96 | 7.22% | Leerink Partners | Michael Cherny | → $60 | Downgrade | Outperform → Market Perform | Get Alert |
| 05/01/2024 | CVS | Buy Now | CVS Health | $55.96 | 3.65% | Cantor Fitzgerald | Sarah James | $87 → $58 | Downgrade | Overweight → Neutral | Get Alert |
| 04/10/2024 | CVS | Buy Now | CVS Health | $55.96 | 55.47% | Cantor Fitzgerald | Sarah James | → $87 | Reiterates | Overweight → Overweight | Get Alert |
| 04/08/2024 | CVS | Buy Now | CVS Health | $55.96 | 35.81% | Wells Fargo | Stephen Baxter | $83 → $76 | Maintains | Equal-Weight | Get Alert |
| 04/04/2024 | CVS | Buy Now | CVS Health | $55.96 | 55.47% | Cantor Fitzgerald | Sarah James | → $87 | Reiterates | Overweight → Overweight | Get Alert |
| 03/15/2024 | CVS | Buy Now | CVS Health | $55.96 | 67.98% | Piper Sandler | Jessica Tassan | $93 → $94 | Maintains | Overweight | Get Alert |
| 03/06/2024 | CVS | Buy Now | CVS Health | $55.96 | 39.39% | Barclays | Andrew Mok | → $78 | Initiates | → Equal-Weight | Get Alert |
| 02/26/2024 | CVS | Buy Now | CVS Health | $55.96 | 57.26% | Leerink Partners | Michael Cherny | → $88 | Initiates | → Outperform | Get Alert |
| 02/08/2024 | CVS | Buy Now | CVS Health | $55.96 | 55.47% | Cantor Fitzgerald | Sarah James | → $87 | Reiterates | Overweight → Overweight | Get Alert |
| 02/08/2024 | CVS | Buy Now | CVS Health | $55.96 | 50.11% | RBC Capital | Ben Hendrix | $86 → $84 | Maintains | Outperform | Get Alert |
| 12/22/2023 | CVS | Buy Now | CVS Health | $55.96 | 67.98% | HSBC | Daniela Bretthauer | → $94 | Initiates | → Buy | Get Alert |
| 12/11/2023 | CVS | Buy Now | CVS Health | $55.96 | 76.91% | TD Cowen | Charles Ryhee | $102 → $99 | Maintains | Outperform | Get Alert |
| 11/21/2023 | CVS | Buy Now | CVS Health | $55.96 | 55.47% | Cantor Fitzgerald | Sarah James | → $87 | Reiterates | Overweight → Overweight | Get Alert |
FAQ
What is the target price for CVS Health (CVS)?
The latest price target for CVS Health (NYSE: CVS) was reported by B of A Securities on May 2, 2024. The analyst firm set a price target for $77.00 expecting CVS to rise to within 12 months (a possible 37.60% upside). 43 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for CVS Health (CVS)?
The latest analyst rating for CVS Health (NYSE: CVS) was provided by B of A Securities, and CVS Health maintained their buy rating.
When was the last upgrade for CVS Health (CVS)?
The last upgrade for CVS Health Corp happened on September 19, 2023 when Evercore ISI Group raised their price target to $83. Evercore ISI Group previously had an in-line for CVS Health Corp.
When was the last downgrade for CVS Health (CVS)?
The last downgrade for CVS Health Corp happened on May 2, 2024 when UBS changed their price target from $85 to $60 for CVS Health Corp.
When is the next analyst rating going to be posted or updated for CVS Health (CVS)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of CVS Health, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for CVS Health was filed on May 2, 2024 so you should expect the next rating to be made available sometime around May 2, 2025.
Is the Analyst Rating CVS Health (CVS) correct?
While ratings are subjective and will change, the latest CVS Health (CVS) rating was a maintained with a price target of $95.00 to $77.00. The current price CVS Health (CVS) is trading at is $55.96, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.